Learning Objectives: Discuss the significant health and treatment issues related to spit tobacco use. List the key components of spit tobacco treatment. Explain the concepts of pharmacologic management.
Abstract: This workshop is directed towards the health care professional who desires more information related to the treatment of their patients who use spit tobacco (ST). Little attention has been paid to ST use or its treatment compared to cigarette smoking. Yet the use of ST in the United States continues to rise in the face of an overall declining smoking prevalence rate. Health care providers have few resources available to guide their treatment of this growing population of tobacco users. A variety of formats will be used to provide a comprehensive review of ST use and give the participant practical information on its treatment. Lecture presentations on terminology, epidemiology and health effects of ST will increase awareness of the prevalence of ST use in the United States, its addictive potential, and the significant negative health consequences of its use. The presenters will review their recent meta-analysis of the published medical literature on the studies of behavioral and pharmacologic treatment of ST dependence. This will be followed by a discussion of their pilot study of bupropion and their experience with residential (inpatient) treatment of ST use. The four key elements of their treatment approach—behavioral therapy, addictive disorders therapy, aggressive pharmacologic therapy, and relapse prevention—will be emphasized. Application of these findings to clinical practice will be described in detail, with illustration of their recommendations through interactive case study reviews.
San Fran Workshop.pps (1808.0 kb)
Back to Spit Tobacco: A Comprehensive Treatment Model
Back to Cessation, Nicotine, and the Science of Addiction
Back to The 2002 National Conference on Tobacco or Health